about
The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issue.Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial.Factors associated with fecal incontinence in a nationally representative sample of diabetic women.A first-in-human pharmacodynamic and pharmacokinetic study of a fully human anti-glucagon receptor monoclonal antibody in normal healthy volunteers.Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study.
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapy for obesity based on gastrointestinal hormones
@ast
Therapy for obesity based on gastrointestinal hormones
@en
Therapy for obesity based on gastrointestinal hormones
@nl
type
label
Therapy for obesity based on gastrointestinal hormones
@ast
Therapy for obesity based on gastrointestinal hormones
@en
Therapy for obesity based on gastrointestinal hormones
@nl
prefLabel
Therapy for obesity based on gastrointestinal hormones
@ast
Therapy for obesity based on gastrointestinal hormones
@en
Therapy for obesity based on gastrointestinal hormones
@nl
P2860
P50
P356
P1476
Therapy for obesity based on gastrointestinal hormones
@en
P2093
Tina Vilsbøll
P2860
P304
P356
10.1900/RDS.2011.8.339
P407
P577
2011-11-10T00:00:00Z